1. Volume 152, Issue 8, Pages 1954-1964 (June 2017)
Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality 
Marina Serper, Tamar H. Taddei, Rajni Mehta, Kathryn D’Addeo, Feng Dai, Ayse Aytaman, Michelle Baytarian, Rena Fox, Kristel Hunt, David S. Goldberg, Adriana Valderrama, David E. Kaplan 
Gastroenterology 
Volume 152, Issue 8, Pages (June 2017)
DOI: /j.gastro
Copyright © 2017 AGA Institute Terms and Conditions

2. Figure 1
First HCC-directed therapy received. Percentage of veterans receiving hepatic resection, liver transplantation, ablative therapies (radiofrequency, microwave, or cryo-ablation), trans-arterial therapies (bland, chemo- or radio-embolization), hospice care, and no active therapy as first intervention stratified by BCLC stage.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2017 AGA Institute Terms and Conditions

3. Figure 2
Unadjusted median survival stratified by BCLC stage. Kaplan-Meier survival analysis of 5-year overall survival shown.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2017 AGA Institute Terms and Conditions

4. Figure 3
Correlation between receipt of active HCC therapy and overall survival at the regional level. Spearman correlation of the proportion of patients receiving active HCC therapy (defined as resection, transplantation, ablation, trans-arterial therapy, or sorafenib) (“Proportion treated”) and median overall survival (OS) in months grouped by Veterans Integrated Service Network region. The diameter of each circle is proportional to the number of HCC cases in each Veterans Integrated Service Network.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2017 AGA Institute Terms and Conditions

5. Supplementary Figure 1
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2017 AGA Institute Terms and Conditions